How to Sterilize Medical Cannabis for Immunocompromised Patients | Research

The takeaway

Cannabis herb carries microorganisms including potentially dangerous molds, and researchers identified sterilization methods that could eliminate infection risk for immunocompromised patients with minimal loss of cannabinoid activity.

Read this if you use medical cannabis while immunocompromised or work with patients who do.

Systematic sterilization can eliminate risk of opportunistic infections

What the researchers found

Researchers addressed a practical safety concern: medical cannabis carries bacteria and fungi on its leaves and flowers that could cause life-threatening infections in immunocompromised patients (such as those undergoing chemotherapy).

They cultured cannabis herb to identify contaminants, tested three sterilization methods, and measured how much cannabinoid activity was lost in each process. The goal was to find the optimal balance between eliminating microbial risk and preserving therapeutic potency.

The study demonstrated that systematic sterilization could eliminate the risk of opportunistic lung infections, particularly from inhaled mold spores, while maintaining clinically useful cannabinoid levels.

Why it matters

Cancer patients and others with compromised immune systems are among those most likely to benefit from medical cannabis for pain, nausea, and appetite. Without sterilization, inhaled cannabis could introduce deadly fungal infections.

The numbers in context

Three sterilization methods compared; cannabinoid activity loss measured for each; primary risk: mold-related opportunistic lung infections; patient populations at risk: cancer patients, transplant recipients, HIV/AIDS patients

How the study worked

Laboratory study culturing cannabis herb for microbial contamination, testing three sterilization methods, and measuring cannabinoid compound activity loss after each treatment.

What this study cannot tell us

Small-scale laboratory study. Did not test the sterilization methods in a clinical setting. Specific cannabinoid compounds measured were limited. May not address all contaminants (pesticides, heavy metals).

How to read the evidence

Practical laboratory study addressing a real clinical need, though limited to in vitro testing without clinical validation.

When this study was published

Published in 2015. Cannabis quality control standards have expanded in many jurisdictions since.

The bigger picture

As medical cannabis becomes more widely prescribed, quality control and safety standards need to match pharmaceutical standards, especially for vulnerable patient populations. This study provided practical guidance for clinical use.

Questions still open

Should all medical cannabis undergo sterilization? What regulatory standards should apply to cannabis products used by immunocompromised patients? Would non-inhaled cannabis products (oils, edibles) carry the same contamination risks?

Common questions

Can medical cannabis cause infections?

Yes, particularly in immunocompromised patients. Cannabis carries mold and bacteria that healthy people can usually handle but that can cause serious lung infections in patients with weakened immune systems from chemotherapy, transplants, or HIV.

Does sterilization destroy the active ingredients?

This study tested three methods and measured cannabinoid loss. The goal was to find approaches that effectively kill microorganisms while preserving as much cannabinoid activity as possible. Some loss was inevitable but could be minimized.

Read the original research

Inhaled medicinal cannabis and the immunocompromised patient.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 23(3), 819-22

View on PubMed ↗Publisher’s paper ↗

Citation

Ruchlemer, Rosa; Amit-Kohn, Michal; Raveh, David; Hanuš, Lumír. (2015). Inhaled medicinal cannabis and the immunocompromised patient.. Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer, 23(3), 819-22. https://doi.org/10.1007/s00520-014-2429-3